topotecan has been researched along with physostigmine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dai, W; Darzynkiewicz, Z; Guzikowski, A; Huang, X; Johnson, G; Lee, B; Naleway, J | 1 |
1 review(s) available for topotecan and physostigmine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for topotecan and physostigmine
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Novel assay utilizing fluorochrome-tagged physostigmine (Ph-F) to in situ detect active acetylcholinesterase (AChE) induced during apoptosis.
Topics: Acetylcholinesterase; Animals; Apoptosis; Biomarkers; Bone Marrow Cells; Caspases; Cell Line, Tumor; Cell Nucleolus; Cytoplasm; Fluorescent Dyes; Gene Expression Regulation, Enzymologic; Humans; Hydrogen Peroxide; Laser Scanning Cytometry; Megakaryocytes; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Motor Endplate; Physostigmine; S Phase; Topotecan | 2005 |